Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Asset Utilization Ratio: 2018-2025

Historic Asset Utilization Ratio for Catalyst Pharmaceuticals (CPRX) over the last 7 years, with Sep 2025 value amounting to 0.57.

  • Catalyst Pharmaceuticals' Asset Utilization Ratio fell 8.26% to 0.57 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.57, marking a year-over-year decrease of 8.26%. This contributed to the annual value of 0.74 for FY2024, which is 20.97% down from last year.
  • Per Catalyst Pharmaceuticals' latest filing, its Asset Utilization Ratio stood at 0.57 for Q3 2025, which was down 3.78% from 0.59 recorded in Q2 2025.
  • Over the past 5 years, Catalyst Pharmaceuticals' Asset Utilization Ratio peaked at 0.90 during Q4 2023, and registered a low of 0.57 during Q3 2025.
  • Its 3-year average for Asset Utilization Ratio is 0.68, with a median of 0.64 in 2024.
  • In the last 5 years, Catalyst Pharmaceuticals' Asset Utilization Ratio tumbled by 40.33% in 2021 and then spiked by 49.16% in 2023.
  • Quarterly analysis of 5 years shows Catalyst Pharmaceuticals' Asset Utilization Ratio stood at 0.61 in 2021, then fell by 1.06% to 0.60 in 2022, then surged by 49.16% to 0.90 in 2023, then tumbled by 32.81% to 0.61 in 2024, then decreased by 8.26% to 0.57 in 2025.
  • Its Asset Utilization Ratio was 0.57 in Q3 2025, compared to 0.59 in Q2 2025 and 0.61 in Q1 2025.